JnJ Ebola vaccine to arrive in Congo in November: Health Authorities
The JnJ vaccine will complement another vaccine manufactured by Merck, which has been administered to more than 225,000 people. It requires two injections eight weeks apart, unlike the Merck vaccine, which requires a single shot.
New Delhi: Health authorities in the Democratic Republic of Congo will introduce a Johnson & Johnson(JnJ) Ebola vaccine in November in the country’s eastern provinces, to counter the current outbreak, they said.
The JnJ vaccine will complement another vaccine manufactured by Merck, which has been administered to more than 225,000 people. It requires two injections eight weeks apart, unlike the Merck vaccine, which requires a single shot.
The first batch of 500,000 doses of the JnJ vaccine should arrive in Congo next week, the authorities said in a statement. The inoculation process will start in Goma in early November and then be extended to other provinces.
Also Read: Merck Ebola vaccine in demand rather than JnJ rival drug
Congolese health authorities had announced the deployment of the vaccine last month but had not specified when the campaign will take place.
Since it first started in August 2018, the Ebola outbreak has killed more than 2,100 people, second only to the 2013-16 outbreak in West Africa that killed more than 11,300.
Next Story
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd